A

Affimed (AFMD)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Affimed (AFMD)

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company's product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research t... Read more

  • USD1.19
  • USD1.24
  • USD1.17
  • USD5.10
  • 3.40%
  • 44M
  • 4.00
  • 1.82M
  • 178M
  • 1.03
  • -69.80%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.